A new report from Advocates for Youth “analyzes youth policies within the President’s Emergency Plan for AIDS Relief (PEPFAR), including its legislative authority, most recent five-year strategy, relevant guidance documents, and all 21 currently available PEPFAR country Partnership Frameworks” and includes “a set of recommendations for the U.S. Congress, [Office of the Global AIDS Coordinator (OGAC)], and Partner Country governments, to design and implement the bold policy needed to support youth sexual and reproductive health and rights, including promotion of comprehensive sexuality education and youth-friendly, integrated, HIV and family planning services,” Advocates for Youth Executive Vice President Debra Hauser writes in an RH Reality Check blog post. She concludes, “In the end, it is young people who hold the key to ending this epidemic. That’s why they should be at the center, not the periphery, of our programs and policies” (4/3).
Programs, Funding & Financing
“The need to ensure that people in Africa have access to essential, high quality, safe and affordable medicines has just received a major boost with the launch of the East African Community (EAC) Medicines Registration Harmonization Project in Arusha, Tanzania, on 30 March 2011,” UNAIDS reports in a feature story on its website. An alliance “bringing together the New Partnership for Africa’s Development (NEPAD), the World Health Organization (WHO), the Bill & Melinda Gates Foundation, the World Bank, the U.K. Department for International Development (DfID), and the Clinton Health Access Initiative (CHAI),” “hope[s] to strengthen regulatory capacity and systems for medicines in Africa, including antiretroviral drugs, so that fewer lives are lost due to drugs which are unsafe and of poor quality or which are largely unavailable or delivered inefficiently,” according to the article (4/2).
In this Reuters opinion piece, finance blogger Felix Salmon responds to a New York Times (NYT) article published on Monday in which journalist Deborah Sontag examines the global response to Haiti’s cholera epidemic. He writes, “There’s no doubt that Haiti’s cholera epidemic was massive and tragic, and that the response to it could have been better, in an ideal world. But Sontag barely attempts to address the question of why the response was suboptimal. … Rather, [she] spends a huge amount of effort tracking down, on the one hand, purely anecdotal stories of individual Haitians who were exposed to the disease, and on the other hand, the detailed story of whether and how the outbreak could be traced back to a group of Nepalese peacekeepers on the island.”
U.S. Government Releases $120M In Emergency Assistance To Help Drought-Affected West African Countries
In a press statement released on Thursday, Secretary of State Hillary Clinton said the U.S. is “‘deeply concerned’ about the humanitarian situation in West Africa” and announced $120 million in emergency assistance, United Press International reports. According to the news service, the U.N. “estimates that more than 15 million people are facing food shortages and malnutrition due to a lingering drought” and “more than one million children are threatened” (3/30).
Funding Shortfalls Could Hinder Implementation Of Treatment As Prevention Strategies, Al Jazeera Reports
Al Jazeera examines the administration of combination antiretroviral therapy (ART) worldwide, focusing on treatment as prevention (TasP), but says current funding levels are insufficient to implement the strategy. The HPTN 052 study showed that HIV-positive people who take ART could reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, according to the news agency. “This research is considered a game changer,” Al Jazeera writes, noting, “2012 may not be the year the international community eliminates HIV, but health experts say it could still be the year where the tide is turned.” The article includes comments from several HIV/AIDS experts (Dalal, 3/31).
The New York Times examines the global response to Haiti’s cholera epidemic, writing that while “[m]any health officials consider the cholera response ‘pretty remarkable,’ as John Vertefeuille, the Centers for Disease Control and Prevention’s director in Haiti, said … [o]thers … believe the bar for success was set too low and more lives could have been saved.” The newspaper continues, “[A]s the deaths and continuing caseload indicate, the world’s response to this preventable, treatable scourge has proved inadequate.”
“That India is free of wild polio today is a testament to the commitment of the Indian government,” which “invested more than $1 billion over the last decade and collaborated with community leaders, health workers, businesses, and parents,” as well as governments, non-governmental organizations, and multilateral agencies, to fight the disease, Health and Human Services (HHS) Secretary Kathleen Sebelius writes in a Foreign Affairs opinion piece. “The victory over the disease in India has saved millions of lives from disability and death. And although the world must remain vigilant against polio to prevent its resurgence, India’s success will gradually allow the nation to focus resources and experience on [other] diseases and initiatives,” she states.
The Center for Global Health Policy’s “Science Speaks” blog reports on a panel discussion hosted on Wednesday by the Consensus for Development Reform and the Modernizing Foreign Assistance Network in Washington, D.C. “Foreign assistance experts discuss[ed] the George W. Bush administration’s legacy on global development, focusing on lessons learned and applying them to the next decade and beyond,” and a central theme was the engagement of the private sector, the blog writes. Panelists highlighted the Millennium Challenge Corporation and PEPFAR, according to the blog (Mazzotta, 3/29).
According to a study recently published in a special supplement of the Journal of Infectious Diseases, half of countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria provide tuberculosis (TB) services in prisons; “even when TB services were provided to prisoners, they were limited in scope; and “[f]ew of the programs receiving a grant from the Global Fund offered services dedicated to the treatment and prevention of multi-drug resistant TB (MDR-TB),” an aidsmap news story reports. TB is a leading cause of death among incarcerated individuals worldwide, aidsmap notes. The study authors concluded, “There is an urgent need to better understand the financing needs and cost-effective service delivery models for tuberculosis care in prisons,” according to the story (Carter, 3/30).
In this New York Times opinion piece, Frank Smithuis, director of Medical Action Myanmar in Yangon, and Nick White, professor of tropical medicine at the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, recount a brief history of the development of anti-malaria drugs and their contribution to “a significant global reduction in malaria” and note that this progress “is now threatened by the emergence of malaria parasites that are resistant to artemisinin on the Cambodia-Thailand border …, the same place where chloroquine resistance emerged 50 years ago and spread across Asia and Africa to claim millions of lives.” They write, “The spread of artemisinin resistance is a very serious threat to health in the tropics. There are currently no drugs that can satisfactorily replace artemisinins.”